These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22446090)

  • 1. 3-(N-arylsulfamoyl)benzamides, inhibitors of human sirtuin type 2 (SIRT2).
    Choi SH; Quinti L; Kazantsev AG; Silverman RB
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2789-93. PubMed ID: 22446090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.
    Sakai T; Matsumoto Y; Ishikawa M; Sugita K; Hashimoto Y; Wakai N; Kitao A; Morishita E; Toyoshima C; Hayashi T; Akiyama T
    Bioorg Med Chem; 2015 Jan; 23(2):328-39. PubMed ID: 25515955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors.
    Khanfar MA; Quinti L; Wang H; Choi SH; Kazantsev AG; Silverman RB
    Eur J Med Chem; 2014 Apr; 76():414-26. PubMed ID: 24602787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.
    Suzuki T; Khan MN; Sawada H; Imai E; Itoh Y; Yamatsuta K; Tokuda N; Takeuchi J; Seko T; Nakagawa H; Miyata N
    J Med Chem; 2012 Jun; 55(12):5760-73. PubMed ID: 22642300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Diketopiperazine-Containing 2-Anilinobenzamides as Potent Sirtuin 2 (SIRT2)-Selective Inhibitors Targeting the "Selectivity Pocket", Substrate-Binding Site, and NAD
    Mellini P; Itoh Y; Elboray EE; Tsumoto H; Li Y; Suzuki M; Takahashi Y; Tojo T; Kurohara T; Miyake Y; Miura Y; Kitao Y; Kotoku M; Iida T; Suzuki T
    J Med Chem; 2019 Jun; 62(12):5844-5862. PubMed ID: 31144814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and validation of SIRT2 inhibitors based on tenovin-6: use of a ¹H-NMR method to assess deacetylase activity.
    Pirrie L; McCarthy AR; Major LL; Morkūnaitė V; Zubrienė A; Matulis D; Lain S; Lebl T; Westwood NJ
    Molecules; 2012 Oct; 17(10):12206-24. PubMed ID: 23079492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT.
    Yagci S; Gozelle M; Kaya SG; Ozkan Y; Aksel AB; Bakar-Ates F; Dundar Y; Eren G
    Bioorg Med Chem; 2021 Jan; 30():115961. PubMed ID: 33360574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Biological Evaluation of 8-Mercapto-3,7-Dihydro-1
    Han H; Li C; Li M; Yang L; Zhao S; Wang Z; Liu H; Liu D
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32549218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected small molecules as novel SIRT2 suicide inhibitors.
    Chen X; Zou Y; Wang J; Cao Z; Liu J; Li Y; Zhao Y; He B
    Bioorg Med Chem; 2020 Mar; 28(6):115353. PubMed ID: 32061485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, in-vitro evaluation and molecular docking studies of novel indole derivatives as inhibitors of SIRT1 and SIRT2.
    Manjula R; Gokhale N; Unni S; Deshmukh P; Reddyrajula R; Srinivas Bharath MM; Dalimba U; Padmanabhan B
    Bioorg Chem; 2019 Nov; 92():103281. PubMed ID: 31561106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach.
    Cui H; Kamal Z; Ai T; Xu Y; More SS; Wilson DJ; Chen L
    J Med Chem; 2014 Oct; 57(20):8340-57. PubMed ID: 25275824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.
    Disch JS; Evindar G; Chiu CH; Blum CA; Dai H; Jin L; Schuman E; Lind KE; Belyanskaya SL; Deng J; Coppo F; Aquilani L; Graybill TL; Cuozzo JW; Lavu S; Mao C; Vlasuk GP; Perni RB
    J Med Chem; 2013 May; 56(9):3666-79. PubMed ID: 23570514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemia.
    Chen X; Wales P; Quinti L; Zuo F; Moniot S; Herisson F; Rauf NA; Wang H; Silverman RB; Ayata C; Maxwell MM; Steegborn C; Schwarzschild MA; Outeiro TF; Kazantsev AG
    PLoS One; 2015; 10(1):e0116919. PubMed ID: 25608039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1 activation with neuroheal is neuroprotective but SIRT2 inhibition with AK7 is detrimental for disconnected motoneurons.
    Romeo-Guitart D; Leiva-Rodríguez T; Espinosa-Alcantud M; Sima N; Vaquero A; Domínguez-Martín H; Ruano D; Casas C
    Cell Death Dis; 2018 May; 9(5):531. PubMed ID: 29748539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse models.
    Chopra V; Quinti L; Kim J; Vollor L; Narayanan KL; Edgerly C; Cipicchio PM; Lauver MA; Choi SH; Silverman RB; Ferrante RJ; Hersch S; Kazantsev AG
    Cell Rep; 2012 Dec; 2(6):1492-7. PubMed ID: 23200855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery of a highly selective 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one SIRT2 inhibitor that is neuroprotective in an in vitro Parkinson's disease model.
    Di Fruscia P; Zacharioudakis E; Liu C; Moniot S; Laohasinnarong S; Khongkow M; Harrison IF; Koltsida K; Reynolds CR; Schmidtkunz K; Jung M; Chapman KL; Steegborn C; Dexter DT; Sternberg MJ; Lam EW; Fuchter MJ
    ChemMedChem; 2015 Jan; 10(1):69-82. PubMed ID: 25395356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Selective SIRT2 Inhibitors as Therapeutic Agents in B-Cell Lymphoma and Other Malignancies.
    Chowdhury S; Sripathy S; Webster A; Park A; Lao U; Hsu JH; Loe T; Bedalov A; Simon JA
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31973227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Evaluation of 3-(Benzylthio)benzamide Derivatives as Potent and Selective SIRT2 Inhibitors.
    Khanfar MA; Quinti L; Wang H; Nobles J; Kazantsev AG; Silverman RB
    ACS Med Chem Lett; 2015 May; 6(5):607-11. PubMed ID: 26005542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylase.
    Taylor DM; Balabadra U; Xiang Z; Woodman B; Meade S; Amore A; Maxwell MM; Reeves S; Bates GP; Luthi-Carter R; Lowden PA; Kazantsev AG
    ACS Chem Biol; 2011 Jun; 6(6):540-6. PubMed ID: 21370928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-((3-Amidobenzyl)oxy)nicotinamides as SIRT2 Inhibitors: A Study of Constrained Analogs.
    Ai T; Wilson DJ; Chen L
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.